{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:06:15Z","timestamp":1788815175109,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.alit.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:31:04Z","timestamp":1760567464000},"page":"175-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Undressing DReSS as p-i mediated disease"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-359X","authenticated-orcid":false,"given":"Werner J.","family":"Pichler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9381-5943","authenticated-orcid":false,"given":"Lester","family":"Thoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-0737","authenticated-orcid":false,"given":"Daniel","family":"Yerly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Peyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8768-1456","authenticated-orcid":false,"given":"Oliver","family":"Hausmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0513-7156","authenticated-orcid":false,"given":"Yannick","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8603-3310","authenticated-orcid":false,"given":"Marianne","family":"Lerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1512-4279","authenticated-orcid":false,"given":"Lukas","family":"Joerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5133-4145","authenticated-orcid":false,"given":"Thomas","family":"Harr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2204-0583","authenticated-orcid":false,"given":"Katja","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2025.08.003_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-Induced Hypersensitivity Syndrome (DIHS)\/Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.08.003_bib3","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1056\/NEJMra2204547","article-title":"Drug reaction with eosinophilia and systemic symptoms","volume":"391","author":"Kroshinsky","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2025.08.003_bib4","article-title":"Advances in understanding the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review","volume":"10","author":"Chen","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.alit.2025.08.003_bib5","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3390\/ijms22042147","article-title":"Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms (DIHS\/DRESS)","volume":"22","author":"Miyagawa","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2025.08.003_bib6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000441280","article-title":"Drug hypersensitivity: how drugs stimulate T cells via pharmacological interaction with immune receptors","volume":"168","author":"Pichler","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib8","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/all.13765","article-title":"Immune pathomechanism and classification of drug hypersensitivity","volume":"74","author":"Pichler","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.alit.2024.08.006","article-title":"Delayed drug hypersensitivity reactions: how p-i transforms pharmacology into immunology","volume":"74","author":"Pichler","year":"2025","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.08.003_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.alit.2025.09.004","article-title":"The Cyto-LTT: a multiplex cytokine assay to detect and assess the strength of T cell reactivity in drug hypersensitivity","volume":"75","author":"Peyer","year":"2026","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.08.003_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000453265","article-title":"Classification of drug hypersensitivity into allergic, p-i, and pseudo-allergic forms","volume":"171","author":"Pichler","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.alit.2025.08.003_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095339","article-title":"Abacavir-induced T cell reactivity represents an allo-immune reaction","volume":"9","author":"Adam","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2025.08.003_bib14","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.alit.2025.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076211","article-title":"Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRV\u03b220-1, altering peptHLA recognition","volume":"8","author":"Watkins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2025.08.003_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4236\/oji.2013.33019","article-title":"Activating interactions of sulfanilamides with T cell receptors","volume":"3","author":"Watkins","year":"2013","journal-title":"Open J Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib18","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1038\/s41467-019-11396-2","article-title":"Identification of drug-specific public TCR driving severe cutaneous adverse reactions","volume":"10","author":"Pan","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.alit.2025.08.003_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/mol.105.021576","article-title":"Transfection of drug specific T cell receptors into hybridoma cells: tools to monitor drug binding to TCR and to evaluate cross-reactivity to related compounds","volume":"70","author":"Schmid","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.alit.2025.08.003_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe0013","article-title":"Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis","volume":"7","author":"Villani","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.alit.2025.08.003_bib21","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1046\/j.1365-2222.1998.00419.x","article-title":"T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction","volume":"28","author":"Schnyder","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2222.2000.00847.x","article-title":"Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions","volume":"30","author":"Yawalkar","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1398-9995.2004.00460.x","article-title":"Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies","volume":"59","author":"Kuechler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib25","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1398-9995.2011.02677.x","article-title":"NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions","volume":"66","author":"Schlapbach","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib26","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1111\/all.15795","article-title":"Drug hypersensitivity and eosinophilia: the decisive role of p-i stimulation","volume":"78","author":"Pichler","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117160","article-title":"Abacavir-reactive memory T cells are present in drug-na\u00efve individuals","volume":"10","author":"Lucas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2025.08.003_bib28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphys.2018.00879","article-title":"Simulation of stimulation: cytokine dosage and cell cycle crosstalk driving timing-dependent T cell differentiation","volume":"9","author":"Barberis","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.alit.2025.08.003_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000236287","article-title":"Nonclassical antigen-presenting cells stimulate the proliferation of Th0 but not Th1\/Th2 clones and modulate the cytokine pattern of T-helper clones","volume":"99","author":"Wyss-Coray","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0161-5890(92)90131-G","article-title":"Mitogen-induced human T cell proliferation is associated with increased expression of selected PKC genes","volume":"29","author":"Isakov","year":"1992","journal-title":"Mol Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.63.3.732","article-title":"Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones","volume":"63","author":"Naisbitt","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.alit.2025.08.003_bib32","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1067\/mai.2003.1507","article-title":"Characterization of drug-specific T cells in lamotrigine hypersensitivity","volume":"111","author":"Naisbitt","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2006.12.617","article-title":"Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity","volume":"119","author":"Wu","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.03.014","article-title":"HLA class II-restricted CD8+ T cells contribute to the promiscuous immune response in dapsone-hypersensitive patients","volume":"141","author":"Zhao","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/cc11441","article-title":"Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics","volume":"16","author":"Schulz","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.alit.2025.08.003_bib36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/cpt.2343","article-title":"Immunopharmacogenomics: mechanisms of HLA-associated drug reactions","volume":"110","author":"Deshpande","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.alit.2025.08.003_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/eji.201142159","article-title":"Avidity determines T-cell reactivity in abacavir hypersensitivity","volume":"42","author":"Adam","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A\u221732:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib39","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.4049\/jimmunol.1302306","article-title":"Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B\u221758:01","volume":"192","author":"Yun","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib40","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.alit.2025.08.003_bib41","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI3544","article-title":"HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes","volume":"102","author":"Zanni","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.alit.2025.08.003_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","article-title":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","volume":"58","author":"Halevy","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib43","first-page":"625","article-title":"Severe drug-induced skin reactions: clinical features, diagnosis, etiology, and therapy","volume":"13","author":"Paulmann","year":"2015","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.alit.2025.08.003_bib44","first-page":"684","article-title":"Syndrome DRESS (drug reaction with eosinophilia and systemic symptoms)","volume":"12","author":"Tehrany","year":"2016","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.alit.2025.08.003_bib45","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1136\/annrheumdis-2014-205577","article-title":"Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin","volume":"74","author":"Chung","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.alit.2025.08.003_bib46","doi-asserted-by":"crossref","first-page":"23827","DOI":"10.1021\/acs.langmuir.5c03118","article-title":"Amphiphilic protein surfactants reduce the interfacial tension of biomolecular condensates","volume":"41","author":"Favetta","year":"2025","journal-title":"Langmuir"},{"key":"10.1016\/j.alit.2025.08.003_bib47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/archderm.143.6.711","article-title":"Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"143","author":"Ziemer","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib48","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJM200108233450814","article-title":"Cutaneous reactions to STI571 (Imatinib)","volume":"345","author":"Brouard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2025.08.003_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/all.15558","article-title":"Viral infections and drug hypersensitivity","volume":"78","author":"Pichler","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib50","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2019.09.036","article-title":"Drug reaction with eosinophilia and systemic symptoms may occur within 2 weeks of drug exposure: a retrospective study","volume":"82","author":"Soria","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib51","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.jaad.2020.03.019","article-title":"Drug reaction with eosinophilia and systemic symptoms within 1 week of exposure to the drug","volume":"83","author":"Sasidharanpillai","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib52","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.jaip.2021.02.060","article-title":"DRESS and AGEP reactions to iodinated contrast media: a French case series","volume":"9","author":"Soria","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.08.003_bib53","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004424-200106000-00002","article-title":"Pharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis","volume":"36","author":"Lorusso","year":"2001","journal-title":"Invest Radiol"},{"key":"10.1016\/j.alit.2025.08.003_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.804605","article-title":"The activation pattern of drug-reacting T cells has an impact on the clinical picture of hypersensitivity reactions","volume":"3","author":"Wuillemin","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib55","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.4049\/jimmunol.1202949","article-title":"HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin","volume":"190","author":"Wuillemin","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib56","article-title":"High cytokine responses and altered T cell activation in DRESS patients at risk for multiple drug hypersensitivity","author":"Thoo","year":"2024","journal-title":"Authorea[Preprint]"},{"key":"10.1016\/j.alit.2025.08.003_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.alit.2025.08.003_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jdermsci.2012.10.002","volume":"69","author":"Ogawa","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.alit.2025.08.003_bib59","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.alit.2025.08.003_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01695920","article-title":"Capillary leak syndrome associated with elevated IL-2 serum levels after allogeneic bone marrow transplantation","volume":"68","author":"Funke","year":"1994","journal-title":"Ann Hematol"},{"key":"10.1016\/j.alit.2025.08.003_bib61","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jaip.2023.02.035","article-title":"Drug reaction with eosinophilia and systemic symptoms: a systematic review","volume":"11","author":"Awad","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.08.003_bib62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2009.02180.x","article-title":"In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases","volume":"65","author":"Zawodniak","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib63","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib64","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/ijd.15196","article-title":"Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review","volume":"60","author":"Yang","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s40629-022-00224-7","article-title":"Treatment with IL-5\/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"32","author":"Gschwend","year":"2023","journal-title":"Allergo J Int"},{"key":"10.1016\/j.alit.2025.08.003_bib66","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/ijms17081214","article-title":"Acute generalized exanthematous pustulosis: pathogenesis, genetic background, clinical variants and therapy","volume":"17","author":"Feldmeyer","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2025.08.003_bib67","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2008.09.015","article-title":"Cutaneous drug eruptions: a 5-year experience","volume":"59","author":"Gerson","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.annder.2019.09.616","article-title":"DRESS avec pustulose et atteinte cardiaque [DRESS syndrome with pustules and cardiac impairment]","volume":"147","author":"Messagier","year":"2020","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.alit.2025.08.003_bib69","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jid.2018.10.023","article-title":"Culprit drugs induce specific IL-36 overexpression in acute generalized exanthematous pustulosis","volume":"139","author":"Meier-Schiesser","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib70","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jaci.2025.01.046","article-title":"IL-36-driven pustulosis: transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP)","volume":"155","author":"Benezeder","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5163129","article-title":"Recent advances in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"2018","author":"Watanabe","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.alit.2025.08.003_bib72","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/ced.12246","article-title":"Increased ratio of FoxP3+ regulatory T cells\/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms","volume":"39","author":"Morito","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002521","article-title":"T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab","volume":"9","author":"Hammond","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.alit.2025.08.003_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00403-024-03061-6","article-title":"Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases","volume":"316","author":"Bray","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.alit.2025.08.003_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002879","article-title":"Nivolumab-associated DRESS in a genetically susceptible individual","volume":"9","author":"Ai","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.alit.2025.08.003_bib76","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2024.05.053","article-title":"Risk factors and drugs associated with the development of drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: a population-based cohort study using the Shizuoka Kokuho database","volume":"91","author":"Ubukata","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib77","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/jamadermatol.2022.3541","article-title":"Risk factors for vancomycin drug reaction with eosinophilia and systemic symptoms syndrome","volume":"158","author":"Blumenthal","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib78","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ACI.0000000000000286","article-title":"Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions","volume":"16","author":"Wang","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib79","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1346-8138.2010.01142.x","article-title":"Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity","volume":"38","author":"Pichler","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/1346-8138.12770","article-title":"Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)","volume":"42","author":"Kano","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib81","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00430-019-00605-w","article-title":"Impact of CMV upon immune aging: facts and fiction","volume":"208","author":"Jergovi\u0107","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/icb.2013.88","article-title":"Phenotypic and transcriptional profile correlates with functional plasticity of antigen-specific CD4+ T cells","volume":"92","author":"Edwards","year":"2014","journal-title":"Immunol Cel Biol"},{"key":"10.1016\/j.alit.2025.08.003_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005832","article-title":"Cytomegalovirus infection leads to development of high frequencies of cytotoxic virus-specific CD4+ T cells targeted to vascular endothelium","volume":"12","author":"Pachnio","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.alit.2025.08.003_bib84","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/all.12138","article-title":"Skin recruitment of monomyeloid precursors involves human herpesvirus-6 reactivation in drug allergy","volume":"68","author":"Hashizume","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib85","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/all.14962","article-title":"The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions","volume":"77","author":"Pichler","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib86","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2025.08.003_bib87","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1398-9995.2011.02720.x","article-title":"Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug-specific T cells","volume":"67","author":"Daubner","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib88","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13601-020-00359-2","article-title":"Drug-related relapses in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"10","author":"J\u00f6rg","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib89","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000458725","article-title":"Multiple drug hypersensitivity","volume":"172","author":"Pichler","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib90","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib91","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In vitro drug causality assessment in Stevens-Johnson syndrome \u2013 alternatives for lymphocyte transformation test","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib92","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.2174\/1381612822666160928125152","article-title":"Severe drug hypersensitivity reactions: clinical pattern, diagnosis, etiology and therapeutic options","volume":"22","author":"Paulmann","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.alit.2025.08.003_bib93","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up","volume":"177","author":"Lee","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib94","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/tpj.2013.40","article-title":"HLA-A\u221731:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis","volume":"14","author":"Genin","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.alit.2025.08.003_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2024.08.039","article-title":"Association of HLA-B13:01 with DRESS and HLA-A31:01 with eosinophilia in SJS\/TEN induced by carbamazepine","volume":"12","author":"Kim","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2025.08.003_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2023.09.282","article-title":"Differential effects of HLA-B\u221715:11 and HLA-A\u221731:01 on carbamazepine-induced cutaneous adverse reactions","volume":"144","author":"Fukunaga","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib97","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/ijpm.ijpm_648_23","article-title":"Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) masquerading as acute leukemia","volume":"68","author":"Gupta","year":"2025","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.alit.2025.08.003_bib98","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/jcpt.13667","article-title":"Clinical features, treatment outcomes and prognostic factors of allopurinol-induced DRESS in 52 patients","volume":"47","author":"Liu","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.alit.2025.08.003_bib99","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1345\/aph.1K522","article-title":"Abacavir hypersensitivity reaction: an update","volume":"42","author":"Hughes","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.alit.2025.08.003_bib100","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.18203\/2319-2003.ijbcp20164147","article-title":"Sequential appearance of four clinical delayed drug hypersensitivity reactions in the same patient","volume":"5","author":"Chularojanamontri","year":"2016","journal-title":"Int J Basic Clin Pharmacol"},{"key":"10.1016\/j.alit.2025.08.003_bib101","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-7-72","article-title":"Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?","volume":"7","author":"Bouvresse","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.alit.2025.08.003_bib102","first-page":"248","article-title":"Peripheral blood eosinophil counts predict the prognosis of drug eruptions","volume":"23","author":"Yang","year":"2013","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.alit.2025.08.003_bib103","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178253","article-title":"Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets","volume":"134","author":"Shah","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.alit.2025.08.003_bib104","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","article-title":"T cell involvement in cutaneous drug eruptions","volume":"31","author":"Hari","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.alit.2025.08.003_bib105","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/bjd.14704","article-title":"Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward","volume":"175","author":"Pinto Gouveia","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib106","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/ced\/llae144","article-title":"Genetic analysis of different subtypes of aseptic pustulosis in the Chinese population","volume":"49","author":"Chen","year":"2024","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.alit.2025.08.003_bib107","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.alit.2025.08.003_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.827893","article-title":"Risk assessment in drug hypersensitivity: detecting small molecules which outsmart the immune system","volume":"3","author":"Pichler","year":"2022","journal-title":"Front Allergy"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025000863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893025000863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T16:45:18Z","timestamp":1774543518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893025000863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1323893025000863"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2025.08.003","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Undressing DReSS as p-i mediated disease","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}